HUNTER SYNDROME
Clinical trials for HUNTER SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HUNTER SYNDROME trials appear
Sign up with your email to follow new studies for HUNTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hunter syndrome drug hunterase passes Long-Term safety check in 30 patients
Disease control CompletedThis study looked at the long-term safety of Hunterase, a drug for Hunter syndrome, in 30 patients who had already completed a previous study or used the drug for over 6 months. The main goal was to check for side effects and changes in lab tests, physical exams, and heart activi…
Matched conditions: HUNTER SYNDROME
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated May 26, 2026 08:24 UTC
-
New study tracks growth in kids with rare disease on enzyme therapy
Disease control CompletedThis study followed 21 children with Hunter Syndrome who started treatment with Elaprase before age 6. Researchers measured changes in height and weight over time to see how the drug affected growth. The study also monitored safety and compared results to untreated patients from …
Matched conditions: HUNTER SYNDROME
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated May 18, 2026 12:11 UTC